Abstract 16496: Relationship Between Sleep Duration and Ideal Cardiovascular Health in a Large Employee Population: The Baptist Health South Florida Employee Study
Introduction: There has been increased focus on the relationship between sleep duration and cardiovascular disease, however, there is limited understanding of the association of sleep duration with cardiovascular health (CVH). In this study we examine the relationship between sleep duration and the American Heart Association’s ideal CVH in a large employee population.
Methods: Data for this study was collected from participants at the 2014 health risk assessment in which they reported their average hours of sleep, their dietary patterns. In person, participants were weighed and their heights were measured. They also had blood pressure, blood glucose, total cholesterol measurements as well as breath carbon monoxide tests for smoking. The ideal for each CVH metric was estimated for each of the 7 metrics. Sleep duration was grouped into less than 6 hours, 6 to 7.9 hours and 8 or more hours. Ideal CVH was classified as presence of 6-7 ideal metrics.
Results: A total of 9700 participants (mean age 43yrs, 74% female) completed the 2014 health risk assessment and had complete data on the variables of interest. Overall, more females and persons without college degrees slept for less than 6 hours. Compared to those with less than 6 hours of sleep, those with 8 or more hours of sleep had 1.6 times the odds of ideal diet (95% CI: 1.1-2.6), 1.7 times the odds of having ideal BMI (95% CI: 1.4-2.1), 1.3 times the odds of having ideal BP (95% CI: 1.1-1.5) and 2.4 times the odds of achieving ideal physical activity (95% CI: 2.4 - 2.9) after controlling for age, sex and educational levels. Comparing to those with less than 6 hours of sleep and with a reference of 0-2 ideal metrics, participants with 8 or more hours of sleep were 2.7 times as likely to have ideal CVH (see figure).
Conclusions: Our study findings underscore the importance of promoting sleep health for optimizing ideal CVH. Further studies are needed to determine generalizability of our results.
Author Disclosures: E. Aneni: A. Employment; Significant; Baptist Health South Florida. A. Younus: None. E. Osondu: None. M. Rouseff: None. S. Das: None. H. Guzman: None. T.H. Tran: None. W. Maziak: None. R. Ahmad: None. M.A. Latif: None. R. Malik: None. O. Ogunmoroti: None. T. Feldman: None. A.S. Agatston: None. E. Veledar: None. K. Nasir: Consultant/Advisory Board; Modest; Regeneron, Quest Diagnostic. Consultant/Advisory Board; Significant; Modest, Modest.
- © 2015 by American Heart Association, Inc.